Copyright Reports & Markets. All rights reserved.

Global and United States Cloning Service Market Report & Forecast 2022-2028

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cloning Service Revenue in Cloning Service Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Cloning Service Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Cloning Service Market Size for the Year 2017-2028
      • 1.2.2 Global Cloning Service Market Size for the Year 2017-2028
    • 1.3 Cloning Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Cloning Service in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Cloning Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Cloning Service Market Dynamics
      • 1.4.1 Cloning Service Industry Trends
      • 1.4.2 Cloning Service Market Drivers
      • 1.4.3 Cloning Service Market Challenges
      • 1.4.4 Cloning Service Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Cloning Service by Gene Type

    • 2.1 Cloning Service Market Segment by Gene Type
      • 2.1.1 Standard Gene
      • 2.1.2 Complex Gene
      • 2.1.3 Other Gene Type
    • 2.2 Global Cloning Service Market Size by Gene Type (2017, 2022 & 2028)
    • 2.3 Global Cloning Service Market Size by Gene Type (2017-2028)
    • 2.4 United States Cloning Service Market Size by Gene Type (2017, 2022 & 2028)
    • 2.5 United States Cloning Service Market Size by Gene Type (2017-2028)

    3 Cloning Service by Application

    • 3.1 Cloning Service Market Segment by Application
      • 3.1.1 Protein Expression and Purification
      • 3.1.2 Genetic Engineering
      • 3.1.3 Vaccine Research
      • 3.1.4 Gene Therapy
      • 3.1.5 Others
    • 3.2 Global Cloning Service Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Cloning Service Market Size by Application (2017-2028)
    • 3.4 United States Cloning Service Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Cloning Service Market Size by Application (2017-2028)

    4 Global Cloning Service Competitor Landscape by Company

    • 4.1 Global Cloning Service Market Size by Company
      • 4.1.1 Top Global Cloning Service Companies Ranked by Revenue (2021)
      • 4.1.2 Global Cloning Service Revenue by Player (2017-2022)
    • 4.2 Global Cloning Service Concentration Ratio (CR)
      • 4.2.1 Cloning Service Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Cloning Service in 2021
      • 4.2.3 Global Cloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Cloning Service Headquarters, Revenue in Cloning Service Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Cloning Service Headquarters and Area Served
      • 4.3.2 Global Cloning Service Companies Revenue in Cloning Service Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Cloning Service Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Cloning Service Market Size by Company
      • 4.5.1 Top Cloning Service Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Cloning Service Revenue by Players (2020, 2021 & 2022)

    5 Global Cloning Service Market Size by Region

    • 5.1 Global Cloning Service Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Cloning Service Market Size by Region (2017-2028)
      • 5.2.1 Global Cloning Service Market Size by Region: 2017-2022
      • 5.2.2 Global Cloning Service Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Cloning Service Market Size YoY Growth 2017-2028
      • 6.1.2 North America Cloning Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Cloning Service Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Cloning Service Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Cloning Service Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Cloning Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Cloning Service Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Cloning Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Cloning Service Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Cloning Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Genscript
      • 7.1.1 Genscript Company Details
      • 7.1.2 Genscript Business Overview
      • 7.1.3 Genscript Cloning Service Introduction
      • 7.1.4 Genscript Revenue in Cloning Service Business (2017-2022)
      • 7.1.5 Genscript Recent Development
    • 7.2 Eurofins Genomics
      • 7.2.1 Eurofins Genomics Company Details
      • 7.2.2 Eurofins Genomics Business Overview
      • 7.2.3 Eurofins Genomics Cloning Service Introduction
      • 7.2.4 Eurofins Genomics Revenue in Cloning Service Business (2017-2022)
      • 7.2.5 Eurofins Genomics Recent Development
    • 7.3 Azenta
      • 7.3.1 Azenta Company Details
      • 7.3.2 Azenta Business Overview
      • 7.3.3 Azenta Cloning Service Introduction
      • 7.3.4 Azenta Revenue in Cloning Service Business (2017-2022)
      • 7.3.5 Azenta Recent Development
    • 7.4 Creative Biogene
      • 7.4.1 Creative Biogene Company Details
      • 7.4.2 Creative Biogene Business Overview
      • 7.4.3 Creative Biogene Cloning Service Introduction
      • 7.4.4 Creative Biogene Revenue in Cloning Service Business (2017-2022)
      • 7.4.5 Creative Biogene Recent Development
    • 7.5 OriGene
      • 7.5.1 OriGene Company Details
      • 7.5.2 OriGene Business Overview
      • 7.5.3 OriGene Cloning Service Introduction
      • 7.5.4 OriGene Revenue in Cloning Service Business (2017-2022)
      • 7.5.5 OriGene Recent Development
    • 7.6 Thermo Fisher Scientific
      • 7.6.1 Thermo Fisher Scientific Company Details
      • 7.6.2 Thermo Fisher Scientific Business Overview
      • 7.6.3 Thermo Fisher Scientific Cloning Service Introduction
      • 7.6.4 Thermo Fisher Scientific Revenue in Cloning Service Business (2017-2022)
      • 7.6.5 Thermo Fisher Scientific Recent Development
    • 7.7 Applied Biological Materials
      • 7.7.1 Applied Biological Materials Company Details
      • 7.7.2 Applied Biological Materials Business Overview
      • 7.7.3 Applied Biological Materials Cloning Service Introduction
      • 7.7.4 Applied Biological Materials Revenue in Cloning Service Business (2017-2022)
      • 7.7.5 Applied Biological Materials Recent Development
    • 7.8 Charles River
      • 7.8.1 Charles River Company Details
      • 7.8.2 Charles River Business Overview
      • 7.8.3 Charles River Cloning Service Introduction
      • 7.8.4 Charles River Revenue in Cloning Service Business (2017-2022)
      • 7.8.5 Charles River Recent Development
    • 7.9 BioServUK
      • 7.9.1 BioServUK Company Details
      • 7.9.2 BioServUK Business Overview
      • 7.9.3 BioServUK Cloning Service Introduction
      • 7.9.4 BioServUK Revenue in Cloning Service Business (2017-2022)
      • 7.9.5 BioServUK Recent Development
    • 7.10 GW Vitek
      • 7.10.1 GW Vitek Company Details
      • 7.10.2 GW Vitek Business Overview
      • 7.10.3 GW Vitek Cloning Service Introduction
      • 7.10.4 GW Vitek Revenue in Cloning Service Business (2017-2022)
      • 7.10.5 GW Vitek Recent Development
    • 7.11 Canvax
      • 7.11.1 Canvax Company Details
      • 7.11.2 Canvax Business Overview
      • 7.11.3 Canvax Cloning Service Introduction
      • 7.11.4 Canvax Revenue in Cloning Service Business (2017-2022)
      • 7.11.5 Canvax Recent Development
    • 7.12 Synbio Technologies
      • 7.12.1 Synbio Technologies Company Details
      • 7.12.2 Synbio Technologies Business Overview
      • 7.12.3 Synbio Technologies Cloning Service Introduction
      • 7.12.4 Synbio Technologies Revenue in Cloning Service Business (2017-2022)
      • 7.12.5 Synbio Technologies Recent Development
    • 7.13 Bioneer Corporation
      • 7.13.1 Bioneer Corporation Company Details
      • 7.13.2 Bioneer Corporation Business Overview
      • 7.13.3 Bioneer Corporation Cloning Service Introduction
      • 7.13.4 Bioneer Corporation Revenue in Cloning Service Business (2017-2022)
      • 7.13.5 Bioneer Corporation Recent Development
    • 7.14 GENEWIZ
      • 7.14.1 GENEWIZ Company Details
      • 7.14.2 GENEWIZ Business Overview
      • 7.14.3 GENEWIZ Cloning Service Introduction
      • 7.14.4 GENEWIZ Revenue in Cloning Service Business (2017-2022)
      • 7.14.5 GENEWIZ Recent Development
    • 7.15 Epoch Life Science
      • 7.15.1 Epoch Life Science Company Details
      • 7.15.2 Epoch Life Science Business Overview
      • 7.15.3 Epoch Life Science Cloning Service Introduction
      • 7.15.4 Epoch Life Science Revenue in Cloning Service Business (2017-2022)
      • 7.15.5 Epoch Life Science Recent Development
    • 7.16 Inovogen Tech
      • 7.16.1 Inovogen Tech Company Details
      • 7.16.2 Inovogen Tech Business Overview
      • 7.16.3 Inovogen Tech Cloning Service Introduction
      • 7.16.4 Inovogen Tech Revenue in Cloning Service Business (2017-2022)
      • 7.16.5 Inovogen Tech Recent Development
    • 7.17 Abace Biotechnology
      • 7.17.1 Abace Biotechnology Company Details
      • 7.17.2 Abace Biotechnology Business Overview
      • 7.17.3 Abace Biotechnology Cloning Service Introduction
      • 7.17.4 Abace Biotechnology Revenue in Cloning Service Business (2017-2022)
      • 7.17.5 Abace Biotechnology Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States Cloning Service Market
      This report focuses on global and United States Cloning Service market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Cloning Service market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Gene Type, Standard Gene accounting for % of the Cloning Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Protein Expression and Purification was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Cloning Service market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Cloning Service Scope and Market Size
      Cloning Service market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cloning Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Cloning Service market size by players, by Gene Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Gene Type, the Cloning Service market is segmented into
      Standard Gene
      Complex Gene
      Other Gene Type
      Segment by Application, the Cloning Service market is segmented into
      Protein Expression and Purification
      Genetic Engineering
      Vaccine Research
      Gene Therapy
      Others
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Cloning Service Market Share Analysis
      Cloning Service market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cloning Service business, the date to enter into the Cloning Service market, Revenue in Cloning Service Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Genscript
      Eurofins Genomics
      Azenta
      Creative Biogene
      OriGene
      Thermo Fisher Scientific
      Applied Biological Materials
      Charles River
      BioServUK
      GW Vitek
      Canvax
      Synbio Technologies
      Bioneer Corporation
      GENEWIZ
      Epoch Life Science
      Inovogen Tech
      Abace Biotechnology

      Buy now